West Pharmaceutical Services (WST) Stock Price, News & Analysis

+14.63 (+3.90%)
(As of 04/23/2024 ET)
Today's Range
50-Day Range
52-Week Range
427,080 shs
Average Volume
509,088 shs
Market Capitalization
$28.55 billion
P/E Ratio
Dividend Yield
Price Target

West Pharmaceutical Services MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.80 Rating Score
11.6% Upside
$435.20 Price Target
Short Interest
1.55% of Float Sold Short
Dividend Strength
Based on Four Factors
Upright™ Environmental Score
News Sentiment
0.63mentions of West Pharmaceutical Services in the last 14 days
Based on 20 Articles This Week
Insider Trading
Selling Shares
$26.65 M Sold Last Quarter
Proj. Earnings Growth
From $7.62 to $9.12 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.80 out of 5 stars

Medical Sector

46th out of 910 stocks

Surgical & Medical Instruments Industry

8th out of 95 stocks

WST stock logo

About West Pharmaceutical Services Stock (NYSE:WST)

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

WST Stock Price History

WST Stock News Headlines

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.
West to Host First-Quarter 2024 Conference Call
WST Apr 2024 450.000 call
West Pharmaceutical Services Inc.
WST Apr 2024 300.000 put
Why West Pharma Is Far From Done
West Announces Second-Quarter 2024 Dividend
See More Headlines
Receive WST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for West Pharmaceutical Services and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 2/7 Dividend
Dividend Payable
Last Earnings
Ex-Dividend for 5/1 Dividend
Next Earnings (Confirmed)
Dividend Payable
Fiscal Year End

Industry, Sector and Symbol

Surgical & medical instruments
Health Care Supplies
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
5 Analysts


Net Income
$593.40 million
Pretax Margin


Sales & Book Value

Annual Sales
$2.95 billion
Cash Flow
$10.67 per share
Book Value
$39.31 per share


Free Float
Market Cap
$28.55 billion

Social Links

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Should I Buy West Pharmaceutical Services Stock? WST Pros and Cons Explained


Here are some ways that investors could benefit from investing in West Pharmaceutical Services, Inc.:

  • West Pharmaceutical Services has received positive analyst ratings, with some analysts upgrading the stock to a "buy" rating, indicating growth potential.
  • The company operates in the surgical & medical instruments industry, which is essential for healthcare, providing stability and demand for its products.
  • Recent insider activity, such as increased stake by institutional investors like Raymond James & Associates, can signal confidence in the company's future performance.
  • West Pharmaceutical Services offers a diverse range of containment and delivery systems for injectable drugs, catering to a wide market and potentially increasing revenue streams.
  • Despite fluctuations, the stock price of West Pharmaceutical Services has shown resilience and growth, making it an attractive option for investors seeking capital appreciation.


Investors should be bearish about investing in West Pharmaceutical Services, Inc. for these reasons:

  • While the company has seen positive analyst ratings, some analysts have issued a "hold" rating, suggesting potential risks or limited short-term growth prospects.
  • The healthcare industry, where West Pharmaceutical Services operates, can be subject to regulatory changes and market uncertainties, impacting the company's performance.
  • Competition in the healthcare supplies subindustry is intense, with other companies vying for market share, potentially affecting West Pharmaceutical Services' profitability.
  • Investing in individual stocks like West Pharmaceutical Services carries inherent risks, including market volatility and company-specific challenges that may impact returns.
  • While the stock price has shown growth, investors should consider conducting thorough research and analysis to assess if the current valuation aligns with the company's fundamentals and future prospects.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, April 10, 2024. Please send any questions or comments about these West Pharmaceutical Services pros and cons to contact@marketbeat.com.

WST Stock Analysis - Frequently Asked Questions

Should I buy or sell West Pharmaceutical Services stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" WST shares.
View WST analyst ratings
or view top-rated stocks.

What is West Pharmaceutical Services' stock price target for 2024?

5 Wall Street analysts have issued 1-year target prices for West Pharmaceutical Services' shares. Their WST share price targets range from $375.00 to $536.00. On average, they expect the company's stock price to reach $435.20 in the next twelve months. This suggests a possible upside of 11.6% from the stock's current price.
View analysts price targets for WST
or view top-rated stocks among Wall Street analysts.

How have WST shares performed in 2024?

West Pharmaceutical Services' stock was trading at $352.12 at the beginning of the year. Since then, WST shares have increased by 10.8% and is now trading at $389.98.
View the best growth stocks for 2024 here

When is West Pharmaceutical Services' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 25th 2024.
View our WST earnings forecast

How can I listen to West Pharmaceutical Services' earnings call?

West Pharmaceutical Services will be holding an earnings conference call on Thursday, April 25th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services, Inc. (NYSE:WST) released its quarterly earnings data on Thursday, February, 15th. The medical instruments supplier reported $1.83 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.78 by $0.05. The medical instruments supplier earned $732 million during the quarter, compared to analysts' expectations of $740.43 million. West Pharmaceutical Services had a trailing twelve-month return on equity of 21.60% and a net margin of 20.12%. West Pharmaceutical Services's revenue for the quarter was up 3.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.77 EPS.
Read the conference call transcript

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services declared a quarterly dividend on Tuesday, February 20th. Investors of record on Wednesday, April 24th will be paid a dividend of $0.20 per share on Wednesday, May 1st. This represents a $0.80 annualized dividend and a yield of 0.21%. The ex-dividend date is Tuesday, April 23rd.
Read our dividend analysis for WST

Is West Pharmaceutical Services a good dividend stock?

West Pharmaceutical Services (NYSE:WST) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.22%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 10.15%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, WST will have a dividend payout ratio of 8.77% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for WST.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services issued an update on its FY 2024 earnings guidance on Friday, February, 16th. The company provided earnings per share guidance of 7.500-7.750 for the period, compared to the consensus EPS estimate of 8.760. The company issued revenue guidance of $3.0 billion-$3.0 billion, compared to the consensus revenue estimate of $3.2 billion.

What is Eric M. Green's approval rating as West Pharmaceutical Services' CEO?

107 employees have rated West Pharmaceutical Services Chief Executive Officer Eric M. Green on Glassdoor.com. Eric M. Green has an approval rating of 75% among the company's employees. 60.0% of employees surveyed would recommend working at West Pharmaceutical Services to a friend.

What other stocks do shareholders of West Pharmaceutical Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include NVIDIA (NVDA), Johnson & Johnson (JNJ), AbbVie (ABBV), Walt Disney (DIS), Home Depot (HD), Visa (V), Alibaba Group (BABA), McDonald's (MCD), Netflix (NFLX) and PepsiCo (PEP).

Who are West Pharmaceutical Services' major shareholders?

West Pharmaceutical Services' stock is owned by many different retail and institutional investors. Top institutional shareholders include Congress Asset Management Co. MA (0.45%), Sumitomo Mitsui Trust Holdings Inc. (0.26%), AMI Asset Management Corp (0.23%), Raymond James & Associates (0.10%), Dudley & Shanley Inc. (0.08%) and Rockland Trust Co. (0.07%). Insiders that own company stock include Annette F Favorite, Bernard Birkett, Chad Winters, Charles Witherspoon, Cindy Reiss-Clark, Eric Mark Green, Quintin J Lai, Silji Abraham and Thomas W Hofmann.
View institutional ownership trends

How do I buy shares of West Pharmaceutical Services?

Shares of WST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does West Pharmaceutical Services have any subsidiaries?
The following companies are subsidiares of West Pharmaceutical Services: Drug Delivery Assets From Plastef Investissements SA, Medimop Medical Projects Ltd., TGPR Holdings Limited, Tech Group Europe Limited (dba West), Tech Group Grand Rapids Inc. (dba West), The Tech Group Inc., W.P.S.F. Limited, WD SG Pte. Ltd., West Analytical Services LLC, West Contract Manufacturing LLC, West Pharma. Services IL Ltd., West Pharmaceutical Packaging (China) Company Ltd., West Pharmaceutical Packaging India Private Limited, West Pharmaceutical Products Ireland Ltd., West Pharmaceutical Services AZ Inc., West Pharmaceutical Services Argentina S.A., West Pharmaceutical Services Asia Ltd., West Pharmaceutical Services Australia Pty. Ltd., West Pharmaceutical Services Beograd d.o.o., West Pharmaceutical Services Brasil Ltda., West Pharmaceutical Services Colombia S.A.S., West Pharmaceutical Services Cornwall Limited, West Pharmaceutical Services Danmark A/S, West Pharmaceutical Services Delaware Acquisition Inc., West Pharmaceutical Services Deutschland GmbH Co KG, West Pharmaceutical Services France S.A.S., West Pharmaceutical Services Group Limited, West Pharmaceutical Services Hispania S.A., West Pharmaceutical Services Holding Danmark ApS, West Pharmaceutical Services Holding France SAS, West Pharmaceutical Services Holding GmbH, West Pharmaceutical Services Holding II GmbH, West Pharmaceutical Services Holding Ireland North Ltd., West Pharmaceutical Services Holding Ireland South Ltd., West Pharmaceutical Services Holding Japan GK, West Pharmaceutical Services Holdings Ltd., West Pharmaceutical Services Italia S.r.L., West Pharmaceutical Services Korea Ltd., West Pharmaceutical Services Lakewood Inc., West Pharmaceutical Services Normandie SAS, West Pharmaceutical Services Shanghai Medical Rubber Products Co. Ltd., West Pharmaceutical Services Singapore (Holding) Pte. Limited, West Pharmaceutical Services Singapore Pte. Ltd., West Pharmaceutical Services Switzerland GmbH, West Pharmaceutical Services Venezuela C.A., West Pharmaceutical Services Verwaltungs GmbH, West Pharmaceutical Services of Delaware Inc., and West Pharmaceutical Services of Florida Inc..
Read More
This page (NYSE:WST) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners